Lexie B2 Plus vs Signia Pure C&G BCT IX
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.
Choice

Lexie B2 Plus
The Lexie B2 Plus is a mid-priced OTC hearing aid that earns an A grade with a SoundScore of 4.4/5 in HearAdvisor's lab testing, ranking #7 among 65 OTC devices. Priced at $899, this behind-the-ear rechargeable device has earned back-to-back Expert's Choice Awards in 2023 and 2024. In our testing, the B2 Plus demonstrates strong speech-in-quiet performance at 4.3/5, which is 1.49 points above the OTC category average. Own-voice comfort is excellent at 4.8/5, measuring 2.29 points above average—a notable strength that may appeal to users who find their own voice bothersome with other devices. Speech-in-noise scores 2.1/5, which is above the category average by 0.58 points but remains mixed in absolute terms, reflecting the broader challenge OTC devices face in noisy environments. The device does show a weakness in feedback handling, scoring 2.8/5—which is 1.74 points below the category average of 4.54/5. Users may encounter occasional whistling during activities that bring objects close to the ear. Music streaming performance is mixed at 2.6/5, though still 0.68 points above the OTC average. The Lexie B2 Plus offers both iPhone and Android streaming compatibility. It's well-suited for users prioritizing clear speech in quieter settings and natural own-voice perception, though those frequently in noisy environments or concerned about feedback stability may want to consider alternatives like the Sony CRE-E10 in this price range.
Choice

Signia Pure C&G BCT IX
The Signia Pure C&G BCT IX is a premium behind-the-ear prescription hearing aid released in 2025, earning an A grade with a SoundScore of 4.4/5 in our lab testing. Priced at $3,398, it ranks #16 among 39 prescription hearing aids tested. In our standardized testing, this device demonstrates particular strength in own-voice comfort, scoring 3.8/5—a solid result that sits 1.10 points above the category average. This makes it a noteworthy option for users who prioritize natural sound quality when speaking. Speech clarity also performs well, with speech-in-quiet at 3.8/5 (+0.39 points above average) and speech-in-noise at 2.5/5 (+0.43 points above average), though the latter remains mixed in absolute terms despite beating the category benchmark. Feedback handling presents an interesting picture: at 4.2/5, it's strong in absolute terms, though it falls 0.52 points below the category average of 4.72/5. Music streaming scores 2.7/5, essentially matching the category average. The device features rechargeable batteries, iPhone and Android streaming, and hands-free functionality. While the Pure C&G BCT IX delivers solid overall performance, shoppers in this premium price tier should note that competitors like the Phonak Sphere Infinio and Oticon Intent score higher in our testing. Budget-conscious buyers may also find comparable sound quality at lower price points from options like the Rexton Reach R-Li T80 at Costco. This hearing aid is best suited for users who value own-voice naturalness and reliable speech clarity in everyday listening situations.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit